Your browser doesn't support javascript.
loading
Inhibition of the cardiac myocyte mineralocorticoid receptor ameliorates doxorubicin-induced cardiotoxicity.
Lother, Achim; Bergemann, Stella; Kowalski, Jessica; Huck, Michael; Gilsbach, Ralf; Bode, Christoph; Hein, Lutz.
Afiliação
  • Lother A; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
  • Bergemann S; Heart Center, Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.
  • Kowalski J; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
  • Huck M; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
  • Gilsbach R; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
  • Bode C; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Albertstr. 25, 79104 Freiburg, Germany.
  • Hein L; Heart Center, Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.
Cardiovasc Res ; 114(2): 282-290, 2018 02 01.
Article em En | MEDLINE | ID: mdl-28430882
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Receptores de Mineralocorticoides / Disfunção Ventricular Esquerda / Antagonistas de Receptores de Mineralocorticoides / Eplerenona Tipo de estudo: Prognostic_studies Idioma: En Revista: Cardiovasc Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Receptores de Mineralocorticoides / Disfunção Ventricular Esquerda / Antagonistas de Receptores de Mineralocorticoides / Eplerenona Tipo de estudo: Prognostic_studies Idioma: En Revista: Cardiovasc Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha